tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Natera price target raised to $250 from $200 at Canaccord
PremiumThe FlyNatera price target raised to $250 from $200 at Canaccord
2d ago
Natera price target raised to $230 from $210 at Barclays
Premium
The Fly
Natera price target raised to $230 from $210 at Barclays
3d ago
Natera’s Strong Q3 Performance and Growth Outlook Drive Buy Rating
Premium
Ratings
Natera’s Strong Q3 Performance and Growth Outlook Drive Buy Rating
3d ago
Natera announces data from PROCEED-CRC trial
PremiumThe FlyNatera announces data from PROCEED-CRC trial
12d ago
Natera Inc.’s New Prenatal Test Study: A Potential Game-Changer in Genetic Screening
Premium
Company Announcements
Natera Inc.’s New Prenatal Test Study: A Potential Game-Changer in Genetic Screening
13d ago
Natera’s New Study: A Potential Game-Changer in Breast Cancer Treatment
Premium
Company Announcements
Natera’s New Study: A Potential Game-Changer in Breast Cancer Treatment
13d ago
Natera’s Strong Position in MRD Market Bolstered by Signatera’s Impact and Potential FDA Approval
PremiumRatingsNatera’s Strong Position in MRD Market Bolstered by Signatera’s Impact and Potential FDA Approval
17d ago
Natera’s Oncology Advancements and Market Potential Drive Buy Rating
Premium
Ratings
Natera’s Oncology Advancements and Market Potential Drive Buy Rating
17d ago
Natera price target raised to $210 from $200 at BTIG
Premium
The Fly
Natera price target raised to $210 from $200 at BTIG
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100